Business Description
G&E Herbal Biotechnology Co Ltd
NAICS : 325411
SIC : 2833
ISIN : TW0004911003
Description
G&E Herbal Biotechnology Co Ltd is a Taiwan based biopharmaceutical company. It is specialized in the production of western conventional drugs, Chinese traditional drugs, unclassified food, cosmetics, and health products. The company is focused on botanical extraction technology and products. Its products include botanical extract toner, total moisture conditioning cream, whitening clear cream and firming essence cream.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 41.39 | |||||
| Equity-to-Asset | 0.89 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.07 | |||||
| Interest Coverage | 4059.43 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 19.96 | |||||
| Beneish M-Score | -2.77 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 85.9 | |||||
| 3-Year Book Growth Rate | 2.8 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 31.03 | |||||
| 9-Day RSI | 39.36 | |||||
| 14-Day RSI | 43.03 | |||||
| 6-1 Month Momentum % | -3.26 | |||||
| 12-1 Month Momentum % | -9.19 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.61 | |||||
| Quick Ratio | 3.41 | |||||
| Cash Ratio | 3.28 | |||||
| Days Inventory | 202.88 | |||||
| Days Sales Outstanding | 18.22 | |||||
| Days Payable | 5.06 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.07 | |||||
| Forward Dividend Yield % | 1.07 | |||||
| 5-Year Yield-on-Cost % | 1.07 | |||||
| Shareholder Yield % | 1.03 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 80.86 | |||||
| Operating Margin % | 44.22 | |||||
| Net Margin % | 39.7 | |||||
| FCF Margin % | 61.21 | |||||
| ROE % | 11.06 | |||||
| ROA % | 10 | |||||
| ROIC % | 12.71 | |||||
| 3-Year ROIIC % | 184.59 | |||||
| ROC (Joel Greenblatt) % | 28.12 | |||||
| ROCE % | 13.96 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 37.84 | |||||
| PE Ratio without NRI | 37.84 | |||||
| Price-to-Owner-Earnings | 29.46 | |||||
| PS Ratio | 14.98 | |||||
| PB Ratio | 4.07 | |||||
| Price-to-Tangible-Book | 4.91 | |||||
| Price-to-Free-Cash-Flow | 24.45 | |||||
| Price-to-Operating-Cash-Flow | 23.74 | |||||
| EV-to-EBIT | 26.83 | |||||
| EV-to-EBITDA | 24.55 | |||||
| EV-to-Revenue | 13.45 | |||||
| EV-to-FCF | 21.98 | |||||
| Price-to-Projected-FCF | 3.21 | |||||
| Price-to-Median-PS-Value | 0.17 | |||||
| Price-to-Graham-Number | 2.87 | |||||
| Price-to-Net-Current-Asset-Value | 12.25 | |||||
| Price-to-Net-Cash | 14.05 | |||||
| Earnings Yield (Greenblatt) % | 3.73 | |||||
| FCF Yield % | 4.09 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
G&E Herbal Biotechnology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 211.149 | ||
| EPS (TTM) (NT$) | 1.414 | ||
| Beta | -1.48 | ||
| Volatility % | 16.35 | ||
| 14-Day RSI | 43.03 | ||
| 14-Day ATR (NT$) | 1.031964 | ||
| 20-Day SMA (NT$) | 54.27217 | ||
| 12-1 Month Momentum % | -9.19 | ||
| 52-Week Range (NT$) | 48.584905 - 60.188679 | ||
| Shares Outstanding (Mil) | 59 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
G&E Herbal Biotechnology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
G&E Herbal Biotechnology Co Ltd Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
G&E Herbal Biotechnology Co Ltd Frequently Asked Questions
What is G&E Herbal Biotechnology Co Ltd(ROCO:4911)'s stock price today?
The current price of ROCO:4911 is NT$53.40. The 52 week high of ROCO:4911 is NT$60.19 and 52 week low is NT$48.58.
When is next earnings date of G&E Herbal Biotechnology Co Ltd(ROCO:4911)?
The next earnings date of G&E Herbal Biotechnology Co Ltd(ROCO:4911) is .
Does G&E Herbal Biotechnology Co Ltd(ROCO:4911) pay dividends? If so, how much?
The Dividend Yield %  of G&E Herbal Biotechnology Co Ltd(ROCO:4911) is 1.07% (As of Today), Highest Dividend Payout Ratio of G&E Herbal Biotechnology Co Ltd(ROCO:4911) was 0. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of G&E Herbal Biotechnology Co Ltd(ROCO:4911) is 1.07%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers